EUVIMEDEUVIMED entdecken
Crossref

Combining Percentage Prostate‐Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High‐Intensity Focused Ultrasound for Prostate Cancer

Po-Fan Hsieh iD, Jun Naruse, Soichiro Yuzuriha, Tatsuya Umemoto, Chi-Ping Huang, Sunao Shoji iD

International Journal of Urology · 2025

DOI: 10.1111/iju.70013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2025. Verfasst von Po-Fan Hsieh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Prostate-Specific Antigen, Prostate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To test the feasibility of combining percentage prostate‐specific antigen (PSA) reduction and multiparametric magnetic resonance imaging (mpMRI) to determine the clinical scenario in which follow‐up biopsy could be avoided after focal therapy (FT) with high‐intensity focused ultrasound (HIFU) for prostate cancer.

Methods

We reviewed 90 men treated with FT. Percentage PSA reduction was calculated by PSA nadir within postoperative 6 months. mpMRI was arranged at postoperative 6 months, followed by routine biopsy. Logistic regression analyses were performed to identify predictors for clinically significant prostate cancer (csPC) on follow‐up biopsy. Receiver operating characteristic curve analysis was done to assess the area under the curve (AUC). The diagnostic performance of percentage PSA reduction and mpMRI to predict csPC was also calculated.

Results

Eight patients had csPC recurrence. Percentage PSA reduction and Prostate Imaging–Reporting and Data System (PI‐RADS) ≥ 3 at postoperative 6 months were predictors for csPC ( p = 0.033 and p = 0.02, respectively). The AUC of mpMRI, percentage PSA reduction, and their combination were 0.95, 0.816, and 0.982, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of PSA reduction < 70% and PI‐RADS ≥ 3 to predict csPC were 87.5%, 69.5%, 21.9%, 98.3%, and 87.5%, 96.3%, 70%, 98.8%, respectively. Using the criteria of PSA reduction < 70% or PI‐RADS ≥ 3 to determine biopsy candidates could avoid 60% of biopsies, without missing csPC.

Conclusion

For patients whose PSA reduction > 70% and PI‐RADS < 3, we suggested avoiding routine biopsy at 6 months after FT with HIFU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMultiparametric Magnetic Resonance ImagingProstate-Specific AntigenProstateUltrasound, High-Intensity Focused, TransrectalNeoplasm Recurrence, LocalHumansMaleAgedMiddle AgedRetrospective StudiesBiopsyFeasibility StudiesUnnecessary ProceduresROC CurvePredictive Value of Tests

Stichwörter der Autor:innen

focal therapymultiparametric magnetic resonance imagingprostate cancerprostate imaging‐reporting and data systemprostate‐specific antigen

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, China Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, China Medical University, Taichung, Taiwan.
  • Department of Urology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.

ORCID-Profile: Po-Fan Hsieh, Sunao Shoji

Zitieren

APA

Hsieh, P. F., Naruse, J., Yuzuriha, S., Umemoto, T., Huang, C. P., & Shoji, S. (2025). Combining Percentage Prostate‐Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High‐Intensity Focused Ultrasound for Prostate Cancer. International Journal of Urology. https://doi.org/10.1111/iju.70013

Vancouver

Hsieh PF, Naruse J, Yuzuriha S, Umemoto T, Huang CP, Shoji S. Combining Percentage Prostate‐Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High‐Intensity Focused Ultrasound for Prostate Cancer. International Journal of Urology. 2025. doi:10.1111/iju.70013

BibTeX
@article{Hsieh2025,
  author = {Hsieh, Po-Fan and Naruse, Jun and Yuzuriha, Soichiro and Umemoto, Tatsuya and Huang, Chi-Ping and Shoji, Sunao},
  title = {Combining Percentage Prostate‐Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High‐Intensity Focused Ultrasound for Prostate Cancer},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70013}
}
Kostenlos starten →